-
公开(公告)号：US08153588B2
公开(公告)日：2012-04-10
申请号：US12822089
申请日：2010-06-23
申请人： John Dietrich , Sverker Ljunghall , Sven Sjögren
发明人： John Dietrich , Sverker Ljunghall , Sven Sjögren
CPC分类号： A61K38/29 , A61K31/138 , A61K31/452 , A61K31/56 , A61K31/59 , A61K31/66 , A61K31/663 , A61K31/675 , A61K45/06 , Y10S514/808 , A61K38/23 , A61K33/06 , A61K31/565 , A61K31/445 , A61K31/135 , A61K2300/00
摘要： The invention relates to a combined pharmaceutical preparation comprising parathyroid hormone and a bone resorption inhibitor, said preparation being adapted for (a) the administration of parathyroid hormone during a period of approximately 6 to 24 months; (b) after the administration of parathyroid hormone has been terminated, the administration of a bone resorption inhibitor during a period of approximately 12 to 36 months.
摘要翻译： 本发明涉及包含甲状旁腺激素和骨吸收抑制剂的组合药物制剂，所述制剂适于（a）在约6至24个月的时间内施用甲状旁腺激素; （b）在甲状旁腺激素的给药已经终止之后，在约12至36个月的时间内施用骨吸收抑制剂。
-
公开(公告)号：US20110071081A1
公开(公告)日：2011-03-24
申请号：US12822089
申请日：2010-06-23
申请人： John Dietrich , Sverker Ljunghall , Sven Sjögren
发明人： John Dietrich , Sverker Ljunghall , Sven Sjögren
CPC分类号： A61K38/29 , A61K31/138 , A61K31/452 , A61K31/56 , A61K31/59 , A61K31/66 , A61K31/663 , A61K31/675 , A61K45/06 , Y10S514/808 , A61K38/23 , A61K33/06 , A61K31/565 , A61K31/445 , A61K31/135 , A61K2300/00
摘要： The invention relates to a combined pharmaceutical preparation comprising parathyroid hormone and a bone resorption inhibitor, said preparation being adapted for (a) the administration of parathyroid hormone during a period of approximately 6 to 24 months; (b) after the administration of parathyroid hormone has been terminated, the administration of a bone resorption inhibitor during a period of approximately 12 to 36 months.
摘要翻译： 本发明涉及包含甲状旁腺激素和骨吸收抑制剂的组合药物制剂，所述制剂适于（a）在约6至24个月的时间内施用甲状旁腺激素; （b）在甲状旁腺激素的给药已经终止之后，在约12至36个月的时间内施用骨吸收抑制剂。
-
公开(公告)号：US07018982B2
公开(公告)日：2006-03-28
申请号：US10389797
申请日：2003-03-18
申请人： John Dietrich , Sverker Ljunghall , Sven Sjögren
发明人： John Dietrich , Sverker Ljunghall , Sven Sjögren
CPC分类号： A61K38/29 , A61K31/138 , A61K31/452 , A61K31/56 , A61K31/59 , A61K31/66 , A61K31/663 , A61K31/675 , A61K45/06 , Y10S514/808 , A61K38/23 , A61K33/06 , A61K31/565 , A61K31/445 , A61K31/135 , A61K2300/00
摘要： The invention relates to a combined pharmaceutical preparation comprising parathyroid hormone and a bone resorption inhibitor, said preparation being adapted for (a) the administration of parathyroid hormone during a period of approximately 6 to 24 months; (b) after the administration of parathyroid hormone has been terminated, the administration of a bone resorption inhibitor during a period of approximately 12 to 36 months.
-
公开(公告)号：US20120148684A1
公开(公告)日：2012-06-14
申请号：US13405093
申请日：2012-02-24
申请人： John Dietrich , Sverker Ljunghall , Sven Sjögren
发明人： John Dietrich , Sverker Ljunghall , Sven Sjögren
CPC分类号： A61K38/29 , A61K31/138 , A61K31/452 , A61K31/56 , A61K31/59 , A61K31/66 , A61K31/663 , A61K31/675 , A61K45/06 , Y10S514/808 , A61K38/23 , A61K33/06 , A61K31/565 , A61K31/445 , A61K31/135 , A61K2300/00
摘要： The invention relates to a combined pharmaceutical preparation comprising parathyroid hormone and a bone resorption inhibitor, said preparation being adapted for (a) the administration of parathyroid hormone during a period of approximately 6 to 24 months; (b) after the administration of parathyroid hormone has been terminated, the administration of a bone resorption inhibitor during a period of approximately 12 to 36 months.
摘要翻译： 本发明涉及包含甲状旁腺激素和骨吸收抑制剂的组合药物制剂，所述制剂适于（a）在约6至24个月的时间内施用甲状旁腺激素; （b）在甲状旁腺激素的给药已经终止之后，在约12至36个月的时间内施用骨吸收抑制剂。
-
公开(公告)号：US06284730B1
公开(公告)日：2001-09-04
申请号：US09125247
申请日：1998-08-14
申请人： John Dietrich , Sverker Ljunghall , Sven Sjögren
发明人： John Dietrich , Sverker Ljunghall , Sven Sjögren
IPC分类号： A61K3816
CPC分类号： A61K38/29 , A61K31/138 , A61K31/452 , A61K31/56 , A61K31/59 , A61K31/66 , A61K31/663 , A61K31/675 , A61K45/06 , Y10S514/808 , A61K38/23 , A61K33/06 , A61K31/565 , A61K31/445 , A61K31/135 , A61K2300/00
摘要： The invention relates to a combined pharmaceutical preparation comprising parathyroid hormone and a bone resorption inhibitor, said preparation being adapted for (a) the administration of parathyroid hormone during a period of approximately 6 to 24 months; (b) after the administration of parathyroid hormone has been terminated, the administration of a bone resorption inhibitor during a period of approximately 12 to 36 months.
摘要翻译： 本发明涉及包含甲状旁腺激素和骨吸收抑制剂的组合药物制剂，所述制剂适于（a）在约6至24个月的时间内施用甲状旁腺激素; （b）在甲状旁腺激素的给药已经终止之后，在约12至36个月的时间内施用骨吸收抑制剂。
-
-
-
-
搜索结果
5 条记录 (耗时 0.008 秒)
